2024 Disease Hospital Radiopharmaceuticals 
AuntMinnie
OCTOBER 2, 2024
The following is the list of candidates for the 2024 edition of the Minnies, AuntMinnie.com 's campaign to recognize the best and brightest in medical imaging. This year, hundreds of candidates have been selected as semifinalists for 14 categories, ranging from Most Influential Radiology Researcher to Best New Radiology Software.
Imaging Technology
MAY 14, 2024
milla1cf Tue, 05/14/2024 - 12:45 May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on their 40-year history of clinical and research collaboration. tesla and 3T scanners. Separately, Varian, a Siemens Healthineers company, will provide linear accelerators.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
JULY 10, 2024
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
AuntMinnie
JULY 10, 2024
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
Imaging Technology
JANUARY 12, 2024
milla1cf Fri, 01/12/2024 - 11:09 January 12, 2024 — RefleXion Medical , Inc., CMS created two new reimbursement codes for use in the hospital outpatient setting, effective Jan. 1, 2024, to describe SCINTIX therapy. For more information: www.reflexion.com Friday, January 12, 2024 - 11:09
Imaging Technology
AUGUST 31, 2023
milla1cf Thu, 08/31/2023 - 15:50 August 31, 2023 — NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals, and Curadh MTR Inc. Ac-225 for use in radiopharmaceutical therapy (RPT). actinium-225 (Ac-225). “As a company at the forefront of U.S.
Imaging Technology
JULY 5, 2023
Ac-225 is a high energy alpha-emitting radioisotope of increasing interest for clinical studies investigating the use of targeted radiopharmaceutical therapy, which combines select molecules with therapeutic radioisotopes to directly target and deliver therapeutic doses of radiation to destroy cancer cells in patients with serious disease.
Expert insights. Personalized for you.
143 
Let's personalize your content